 |
PDBsum entry 2c6u
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Biol Chem
282:3165-3172
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2.
|
|
A.A.Watson,
J.Brown,
K.Harlos,
J.A.Eble,
T.S.Walter,
C.A.O'Callaghan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The human C-type lectin-like molecule CLEC-2 is expressed on the surface of
platelets and signaling through CLEC-2 causes platelet activation and
aggregation. CLEC-2 is a receptor for the platelet-aggregating snake venom
protein rhodocytin. It is also a newly identified co-receptor for human
immunodeficiency virus type 1 (HIV-1). An endogenous ligand has not yet been
identified. We have solved the crystal structure of the extracellular domain of
CLEC-2 to 1.6-A resolution, and identified the key structural features involved
in ligand binding. A semi-helical loop region and flanking residues dominate the
surface that is available for ligand binding. The precise distribution of
hydrophobic and electrostatic features in this loop will determine the nature of
any endogenous ligand with which it can interact. Major ligand-induced
conformational change in CLEC-2 is unlikely as its overall fold is compact and
robust. However, ligand binding could induce a tilt of a 3-10 helical portion of
the long loop region. Mutational analysis and surface plasmon resonance binding
studies support these observations. This study provides a framework for
understanding the effects of rhodocytin venom binding on CLEC-2 and for
understanding the nature of likely endogenous ligands and will provide a basis
for rational design of drugs to block ligand binding.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.M.Kerrigan,
and
G.D.Brown
(2010).
Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs.
|
| |
Immunol Rev,
234,
335-352.
|
 |
|
|
|
|
 |
C.Chaipan,
I.Steffen,
T.S.Tsegaye,
S.Bertram,
I.Glowacka,
Y.Kato,
J.Schmökel,
J.Münch,
G.Simmons,
R.Gerardy-Schahn,
and
S.Pöhlmann
(2010).
Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.
|
| |
Retrovirology,
7,
47.
|
 |
|
|
|
|
 |
C.E.Hughes,
A.Y.Pollitt,
J.Mori,
J.A.Eble,
M.G.Tomlinson,
J.H.Hartwig,
C.A.O'Callaghan,
K.Fütterer,
and
S.P.Watson
(2010).
CLEC-2 activates Syk through dimerization.
|
| |
Blood,
115,
2947-2955.
|
 |
|
|
|
|
 |
C.Huysamen,
and
G.D.Brown
(2009).
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors.
|
| |
FEMS Microbiol Lett,
290,
121-128.
|
 |
|
|
|
|
 |
T.L.Hsu,
S.C.Cheng,
W.B.Yang,
S.W.Chin,
B.H.Chen,
M.T.Huang,
S.L.Hsieh,
and
C.H.Wong
(2009).
Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins.
|
| |
J Biol Chem,
284,
34479-34489.
|
 |
|
|
|
|
 |
A.A.Watson,
J.A.Eble,
and
C.A.O'Callaghan
(2008).
Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2.
|
| |
Protein Sci,
17,
1611-1616.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.M.Christou,
A.C.Pearce,
A.A.Watson,
A.R.Mistry,
A.Y.Pollitt,
A.E.Fenton-May,
L.A.Johnson,
D.G.Jackson,
S.P.Watson,
and
C.A.O'Callaghan
(2008).
Renal cells activate the platelet receptor CLEC-2 through podoplanin.
|
| |
Biochem J,
411,
133-140.
|
 |
|
|
|
|
 |
E.Hooley,
E.Papagrigoriou,
A.Navdaev,
A.V.Pandey,
J.M.Clemetson,
K.J.Clemetson,
and
J.Emsley
(2008).
The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure.
|
| |
Biochemistry,
47,
7831-7837.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |